A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.
Clinical trial NCT04923048 · UNKNOWN
Trial details
- NCT number
- NCT04923048
- Sponsor
- Genor Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2024-06-28
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.